Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Growth

Add To Compare

NAV on April 17, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 1,229 cr
Turnover Ratio 11.18%
Expense Ratio 0.72%
Exit Load 0.25%if redeemed within
30 Days
0.00%if redeemed after 30 Days
Returns
  • 1M: 1.90%
  • 1Y: 3.11%
  • 3M: -0.71%
  • 3Y: 23.68%
  • 6M: -4.44%
  • 5Y: 15.10%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since over 1 year)
ISIN INF277K019A3
Fund Family Tata
P/E Ratio 38.31
P/B Ratio 5.88
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha -0.23
Beta 0.97
R-Squared 93.92
Info Ratio -0.22
Tracking Err 4.18
Sortino 1.602
Sharpe 0.930
Std Dev 16.865
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.63%
Industrial 0.0%
Technology 0.0%
Basic Materials 5.05%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 94.33%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet

-
Best Sector Healthcare Funds
NAME LATEST
NAV
RETURNS
1y    
FUND
ASSETS
Expense
RATIO
RISK
16.084 9.92% 327 cr 0.83% -
44.015 9.47% 2,754 cr 0.51% -
324.116 7.55% 1,056 cr 1.29% -
42.020 7.00% 6,293 cr 1.04% -
496.821 5.26% 4,064 cr 0.92% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata